ORKA
Oruka Therapeutics, Inc. Common StockData: 2026-11-12
Quick Stats
Nov 12, 202636.3
AI Score
EXTENDED0.57
Volume Ratio
TBA
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
ORKA Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
ORKA Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
ORKA Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ORKA Daily Out of Money Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ORKA Daily In the Money Options - Sort by Max open Interest (near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ORKA Most Active Options by Volume(near term)
12th November 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ORKA Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ORKA Stock Summary
Last updated Nov 12, 2026
ORKA is currently trading at $105.24, positioned above its 200-day moving average of $72.31, indicating a long-term uptrend. The stock has a 52-week range of $25.23 to $115.515.
Technical Analysis: The 50-day moving average stands at $89.4, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.405, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.115, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ORKA at 36.3/100 with a EXTENDED recommendation.
ORKA (Oruka Therapeutics, Inc. Common Stock) Indicators
Last updated Nov 12, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 65.405 |
| CMF (20) | 0.115 |
| ROC (10) | 9.426 |
| ADX (14) | 35.025 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 5.629 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -23.928 |
| MFI (14) | 87.821 |
ORKA Candlestick Patterns
No validated candlestick patterns fired for ORKA in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Oruka Therapeutics, Inc. Common Stock is above both the 50 Day and 200 Day SMA which is considered Bullish.
ORKA Moving Averages Analysis
Oruka Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Nov 12, 2026
Oruka Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Nov 12, 2026
ORKA (Oruka Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Nov 12, 2026
| Days | MA |
|---|---|
| 10 | 101.91 |
| 20 | 93.23 |
| 30 | 88.72 |
| 50 | 89.4 |
| 100 | 92.23 |
| 200 | 72.31 |
ORKA Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 7.2 billion |
| Earnings/Share ($) | -2.12 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -2.5163 |
| EPS Estimate Next Year ($) | -2.9442 |
| WallStreet Target Price ($) | 156.17 |
| Most Recent Quarter |
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.